Literature DB >> 1570020

Disposition of endogenous adrenaline compared to noradrenaline released by cardiac sympathetic nerves in the anaesthetized dog.

G Eisenhofer1, J J Smolich, M D Esler.   

Abstract

The fate of adrenaline released from cardiac sympathetic nerves was compared with that of noradrenaline before and during two periods of electrical stimulation of the left ansa subclavia in eight anaesthetized dogs. Cardiac spillovers and extractions of both catecholamines were estimated simultaneously using infusions of 3H-labelled adrenaline and noradrenaline. Animals were studied before and after neuronal uptake blockade with desipramine. Cardiac spillover of adrenaline, detectable at rest at 1.4 +/- 0.3 pmol/min, increased to 4.0 +/- 1.1 and 5.3 +/- 1.2 pmol/min during sympathetic stimulation. Cardiac noradrenaline spillover increased from 49 +/- 12 to 205 +/- 40 and 451 +/- 118 pmol/min. After desipramine, cardiac spillovers of adrenaline were decreased, whereas those of noradrenaline were increased so that the ratio of adrenaline to noradrenaline spillover, meaned before and during stimulation, decreased substantially from 1:42 to 1:166. The desipramine-induced decrease in cardiac extractions of 3H-labelled catecholamines indicated adrenaline was removed 60% less efficiently than noradrenaline by neuronal uptake, whereas the extractions remaining indicated adrenaline was removed 50% more efficiently by extraneuronal uptake. The differences in removal processes indicated that 35% of the adrenaline released by cardiac sympathetic nerves was recaptured compared to 88% for noradrenaline, leaving 53% to be removed extra-neuronally compared to 6.6% for noradrenaline, so that proportionally more released adrenaline than noradrenaline escaped to spillover into plasma (12% versus 5.4%). Since extra-neuronal uptake was more efficient for adrenaline than noradrenaline, proportionally less released adrenaline than noradrenaline escaped local removal to spillover into plasma when neuronal uptake was blocked (17% versus 45%). This reversed the situation before blockade so that desipramine substantially decreased the ratio of adrenaline to noradrenaline spillover. Thus, differences in the efficiencies of neuronal or extraneuronal uptake are important determinants of the amounts of locally released adrenaline and noradrenaline that escape removal processes to act at neuroeffector sites or spillover into plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570020     DOI: 10.1007/bf00165731

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  UPTAKE AND RELEASE OF DEXTRO- AND LAEVO-ADRENALINE IN NORADRENERGIC STORES.

Authors:  N E ANDEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1964

2.  THE UPTAKE OF ADRENALINE BY THE RAT ISOLATED HEART.

Authors:  L L IVERSEN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  Rudolf Buchheim lecture. The metabolizing systems involved in the inactivation of catecholamines.

Authors:  U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

4.  Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.

Authors:  P C Chang; K Szemeredi; E Grossman; I J Kopin; D S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

5.  Desipramine inhibits sympathetic nerve activity in the rabbit.

Authors:  B Sazbo; A Schultheiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

6.  Differences in the neuronal removal of circulating epinephrine and norepinephrine.

Authors:  G Eisenhofer; M D Esler; H S Cox; I T Meredith; G L Jennings; J E Brush; D S Goldstein
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

7.  Chronic renal venous catheterization in fetal sheep.

Authors:  H S Iwamoto; A M Rudolph
Journal:  Am J Physiol       Date:  1983-09

8.  Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.

Authors:  G Eisenhofer; J J Smolich; H S Cox; M D Esler
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

9.  Is adrenaline released by sympathetic nerves in man?

Authors:  M Esler; G Eisenhofer; J Chin; G Jennings; I Meredith; H Cox; G Lambert; J Thompson; A Dart
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

10.  Effects of desipramine hydrochloride on peripheral sympathetic nerve activity.

Authors:  M D Cohen; J Finberg; M Dibner-Dunlap; S N Yuih; M D Thames
Journal:  Am J Physiol       Date:  1990-04
View more
  10 in total

1.  Synthesis and bioevaluation of [(18)F]4-fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG): a novel radiotracer for quantitative PET studies of cardiac sympathetic innervation.

Authors:  Keun Sam Jang; Yong-Woon Jung; Phillip S Sherman; Carole A Quesada; Guie Gu; David M Raffel
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

2.  Reply: Platelet noradrenaline uptake is unrelated to renal denervation.

Authors:  Nicolas Barber-Chamoux; Murray D Esler
Journal:  Nat Rev Cardiol       Date:  2016-09-22       Impact factor: 32.419

3.  Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover.

Authors:  A Aneman; G Eisenhofer; L Olbe; J Dalenbäck; P Nitescu; L Fändriks; P Friberg
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

4.  Computational modeling reveals multiple abnormalities of myocardial noradrenergic function in Lewy body diseases.

Authors:  David S Goldstein; Mark J Pekker; Graeme Eisenhofer; Yehonatan Sharabi
Journal:  JCI Insight       Date:  2019-07-23

Review 5.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

6.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

7.  Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats.

Authors:  Remya Robinson; Amee Krishnakumar; C S Paulose
Journal:  Cell Mol Neurobiol       Date:  2009-01-09       Impact factor: 5.046

8.  Sustained prejunctional facilitation of noradrenergic neurotransmission by adrenaline as a co-transmitter in the portal vein of freely moving rats.

Authors:  R P Coppes; F Brouwer; I Freie; J Smit; J Zaagsma
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

9.  The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+).

Authors:  H Russ; M Gliese; J Sonna; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

10.  Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors.

Authors:  David M Raffel; Yong-Woon Jung; David L Gildersleeve; Phillip S Sherman; James J Moskwa; Louis J Tluczek; Wei Chen
Journal:  J Med Chem       Date:  2007-04-10       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.